Skip to content
PHOENIX-Logo
  • Home
  • Company
    • About Us
    • Our Board
    • Our Milestones
    • Our Collaborators
  • Technology & Products
    • Confidentiality of Technology and Products
    • OPAL Process
    • OPAL A
    • Intellectual Property
    • Future Patents
  • Scientific & Clinical
    • Confidentiality of Results of Scientific & Clinical Research
    • Scientific Research
    • Clinical Research
  • Publications & Presentations
    • Confidentiality of Publications & Presentations
    • Published Academic Papers
    • Conference Presentations
    • Poster Presentations
    • Published Articles
    • Clinical Reports
  • Contact Us
×
  • Home
  • Company
    • About Us
    • Our Board
    • Our Milestones
    • Our Collaborators
  • Technology & Products
    • Confidentiality of Technology and Products
    • OPAL Process
    • OPAL A
    • Intellectual Property
    • Future Patents
  • Scientific & Clinical
    • Confidentiality of Results of Scientific & Clinical Research
    • Scientific Research
    • Clinical Research
  • Publications & Presentations
    • Confidentiality of Publications & Presentations
    • Published Academic Papers
    • Conference Presentations
    • Poster Presentations
    • Published Articles
    • Clinical Reports
  • Contact Us

Conference Presentations

Home » Publications » Conference Presentations

Baldock M, OPAL A for the preventative treatment and management of chronic wounds for Aged Care providers: A model for change; Australian Wound Management Association Conference, Gold Coast, Queensland, May 2014

Mitchell G, Windegger T & Russell FD, Clinical observations and physiological data supporting a vascular response as a mechanism of the novel wound-healing agent OPAL A; Australasian Wound & Tissue Repair Society Conference, Perth, Western Australia, March 2010

Mitchell G, McArthur T, Hollerbach K & Richardson M, Alkalised fruit extract as a potential treatment for chronic ulcers – a case series; Australian Wound Management Association Conference, Darwin, Northern Territory, May 2008

PHOENIX

Phoenix Eagle is a biopharmaceutical research and development company with a robust product pipeline based on its unique OPAL technology

Quick Links

  • Home
  • Company
  • Technology and Products
  • Scientific & Clinical Research
  • Publications & Presentations
  • Contact Us

Contact Us

Phoenix Eagle Company Pty Ltd
Suite 5
531 Hay Street
Subiaco, WA 6008
Australia
Tel: 0419 094 748
Email: business@phoenixeaglecompany.com

© 2023 Phoenix Eagle Company. All Rights Reserved. Site by DeCODE | Privacy Policy